Dana-Farber Scientists to Showcase Over 50 Research Studies at AACR Annual Meeting 2026
Dana-Farber Cancer Institute researchers are set to unveil over 50 groundbreaking studies at the upcoming American Association for Cancer Research ...
Tag: oncology drug development
New UPLC-MS/MS Method for Asciminib and Shikonin Study
In the ever-evolving landscape of pharmacology and toxicology, the need for precise and innovative methodologies to quantify drugs and investigate ...
Assessing Dose Metrics in Oncology Drug Evaluations
The complex landscape of oncology drug development has long been a subject of intensive research and debate, particularly regarding how ...
Novel ADC Targets Fucosyl-GM1 in Lung Cancer
In an exciting development in the realm of cancer therapeutics, researchers have unveiled a novel antibody-drug conjugate (ADC) known as ...
Breakthrough First-in-Class Covalent Werner Helicase Inhibitor Demonstrates Clinical Proof-of-Concept in Phase I Trial
In a landmark development in the field of oncology and targeted cancer therapies, researchers at The University of Texas MD ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!